Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06370572 · ClinicalTrials.gov registry record · NA
Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments
A NA study of Dementia and Emergency Department Patient, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 714
- Enrollment target
- 2
- Study locations
NCT06370572: Completed NA study of Dementia and Emergency Department Patient, sponsored by University of Chicago.
NCT06370572 is a NA study of Dementia and Emergency Department Patient that has completed, run by University of Chicago. The registered enrollment target is 714 participants, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06370572, a NA study of Dementia and Emergency Department Patient, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 714 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn if the Pain in Advanced Dementia (PAINAD) scale can improve emergency pain care in persons living with dementia (PLWD). It is hypothesized that a PAINAD electronic health record (EHR) prompt that appears to emergency department (ED) staff will enable them to accurately assess pain levels and lead to better pain treatment for PLWD.
Primary Outcome
Measured by numbers of patients
Conditions Studied
Interventions
- OTHER PAINAD EHR Prompt
Study Locations (2)
Illinois
- University of Chicago - Chicago
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 714 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the finished NCT06370572 record still lists
NCT06370572 is an interventional study that assigns participants to a tested intervention. The registered 714 participants enrollment target is mid-sized for trials with a published cap, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which PAINAD EHR Prompt is the first listed.
NCT06370572 reports a single indexed study location in Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06370572 about?
NCT06370572 is a clinical study titled "Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments". The purpose of this study is to learn if the Pain in Advanced Dementia (PAINAD) scale can improve emergency pain care in persons living with dementia (PLWD). It is hypothesized that a PAINAD electronic health record (EHR) prompt that appears to emergency department (ED) staff will enable them to acc...
What is the current status of trial NCT06370572?
This trial is currently completed. It is a NA study. The enrollment target is 714 participants. The study started on 2024-08-19. Estimated completion is 2025-09-30.
What conditions does trial NCT06370572 study?
This clinical trial studies the following conditions: Dementia, Emergency Department Patient, Hip Pain, Pain in Advanced Dementia Scale.
What interventions are being tested in trial NCT06370572?
The interventions under investigation include: PAINAD EHR Prompt (OTHER).
Who is sponsoring clinical trial NCT06370572?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06370572 being conducted?
This trial has 2 study locations across Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06370572's enrollment target sits among peer trials
714 40th of 199 higher than 160 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI